Supriya Lifescience Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

16.10

16.10

16.10

16.10

14.64

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

980.66

799.27

683.36

599.59

253.95

Loan funds

Secured loans

-

-

16.63

21.30

67.41

Unsecured loans

-

-

-

-

-

Total

996.76

815.37

716.08

636.98

335.99

Uses of funds

Fixed assets

Gross block

531.62

368.86

302.98

220.30

122.21

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

78.76

58.73

41.44

30.53

22.17

Net block

452.87

310.13

261.54

189.77

100.04

Capital work-in-progress

148.02

148.83

67.63

43.41

78.79

Investments

63.24

63.80

25.30

0.05

0.05

Net current assets

Current assets, loans & advances

448.19

398.49

465.82

501.53

266.59

Less : current liabilities & provisions

115.55

105.87

104.19

97.78

109.47

Total net current assets

332.64

292.62

361.62

403.75

157.11

Miscellaneous expenses not written

-

-

-

-

-

Total

996.76

815.37

716.08

636.98

335.99

Notes:

Book value of unquoted investments

63.24

63.80

25.30

0.05

0.05

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

4.17

3.46

5.62

5.62

1.57

Number of equity sharesoutstanding (Lacs)

804.83

804.83

804.83

804.83

731.84